Serotonin antagonists for use as antiglaucoma agents and their ocular penetration

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 43, Issue 3, 1997, Pages 273-281

  Schoenwald, Ronald D ^a   Gadiraju, Ramakrishna R ^a   Barfknecht, Charles F ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Absorption; Antiglaucoma agents; Distribution; Intraocular pressure; Permeability coefficients; Rabbits; Serotonin antagonists

Indexed keywords

1 PHENYLPIPERAZINE DERIVATIVE; 1 PHENYLPIPERIDINE; ANTIGLAUCOMA AGENT; DIETHYLAMINE; DRUG CARRIER; KETANSERIN; MORPHOLINE DERIVATIVE; PIPERAZINE DERIVATIVE; PIPERIDINE DERIVATIVE; SEROTONIN ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG PENETRATION; DRUG SOLUBILITY; DRUG TISSUE LEVEL; GLAUCOMA; INTRAOCULAR PRESSURE; NONHUMAN; ORAL DRUG ADMINISTRATION; RABBIT; TOPICAL DRUG ADMINISTRATION;

EID: 0031401881     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-6411(97)00055-6     Document Type: Article

References (22)

1. U. Meyer-Bothling, A.J. Bron, N.N. Osborne, Topical application of serotonin or the 5-HT1-agonist 5-CT intraocular pressure in rabbits. Inv. Ophthalmol. Vis. Sci., 34 (1993) 3035-3042.
2. P. Mallorga, M.F. Sugrue, Characterization of serotonin receptors in the iris + ciliary body of the albino rabbit, Curr. Eye Res., 6 (1987) 527-532.
3. C. Costagliola, G. Iuliano, M. Rinaldi, V. Russo, G. Scibelli, L. Mastropasqua, Effect of topical ketanserin administration on intraocular pressure. Br. J. Ophthal., 77 (1993) 344-348.
4. C. Costagliola, G. Scibelli, M.L. Fasano, L.A. Ferrara, L. Mastropassqua, Effect of oral ketanserin administration on intraocular pressure in glaucomatous patients. Exp. Eye Res., 52 (1991) 507-510.
5. C. Costagliola, M.L. Fasano, G. Iuliano, L.A. Ferrara, Effects of Ketanserin on Intraocular Pressure, Cardiovasc. Drugs Therapy, 4 (1990) 97-99.
6. S.J. Peroutka, The Molecular Pharmacology of 5-Hydroxytryptamine Receptor Subtypes. In: Serotonin Receptor Subtypes: Basic and Clinical Aspects. Wiley-Liss, New York, 1991, pp. 65-80.
7. A.B. Tobin, W. Unger, N.N. Osborne, Evidence for the presence of serotonergic nerves and receptors in the iris-ciliary body complex of the rabbit. J. Neurosci., 8 (1988) 3713-3721.
8. Krootila, K., Palkama, A., Uusitalo, H., Effect of serotonin and its antagonist (keranserin) on intraocular pressure in the rabbit. J. Ocular Pharmacol., 3 (1987) 279-290.
9. N.L. Barnett, N.N. Osborne, The Presence of serotonin (5-HT1) receptors negatively coupled to adenylate cyclase in rabbit and human iris-ciliary processes. Exp. Eye Res., 57 (1993) 209-216.
10. J.L. Herndon, S.P. Ismaiel, Ingher, M. Teitler, R.A. Glennon, Ketanserin analogues: Structure-affinity relationships for 5-HT2 and 5-HT1C serotonin receptor binding. J. Med. Chem. 35 (1992) 4903-4910.
11. F.W. Chang, J.S. Burke, D.E. Potter, Mechanism of the ocular hypotensive action of ketanserin. J. Ocular. Pharmacol., 1 (1985) 137-147.
12. S.J. Peroutka, 5-Hydroxytryptamine receptor subtypes. Ann. Rev. Neurosci., 11 (1988) 45-60.
13. J.E. Audia, M.L. Cohen, Serotonin modulators and cardiovascular gastrointestinal diseases. Annual Report in Medicinal Chemistry, 26 (1991) 103-112.
14. Albert, A., Serjeant, E.P. The Determination of Ionization Constants, Chapman and Hall, London, 1971.
15. C. Hansch, Appendix I, in: Purcell, W.P., Bass G.E., Clayton, G.M. (Eds.), Strategy of Drug Design, Wiley, New York, 1973.
16. M.G. Eller, R.D. Schoenwald, J.A. Dixson, Segarra, C.F. Barfknecht, Topical Carbonic anhydrase inhibitors III: Optimization model for corneal penetration of ethoxzolamide analogues. J. Pharm. Sci., 74 (1985) 155-160.
17. H.F. Edelhauser, T.H. Maren, Permeability of human cornea and sclera to sulfonamide carbonic anhydrase inhibitors, Arch. Ophthalmol., 106 (1988) 1110-1115.
18. W. Wang, H. Sasaki, D.S. Chien, Lipophilicity influence on conjunctival drug penetration in the pigmented rabbit: a comparison with comeal penetration. Curr. Eye Res., 10 (1991) 571-579.
19. S. Hitoshi, Y. Igarashi, T. Nagono, K. Nishida, J. Nakamura, Different effects of absorption on corneal and conjunctival penetration of ophthalmic beta-blockers, Pharm. Res., 12 (1995) 1146-1150.
20. P. Vareilles, V.J. Lotti, Effect of timolol on aqueous humor dynamics in the rabbit. Ophthalmic Res., 13 (1981) 72-77.
21. R.D. Schoenwald, Chemical delivery systems with enhanced phar nacokinetic properties, in: Mitra, A.K., (Ed.) Ophthalmic Drug Delivery Systems. Marcel Dekker, New York, 1993. pp. 307-330.
22. C.S. Foster, M.S. de la Maza, Stuctural considerations of the sclera, in: The Sclera, Springer, New York, 1994, pp. 10-32.